(Q42442829)

31 October 2017

title

Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer (English)

1 reference

31 October 2017

Aye Aye Thike

1

1 reference

31 October 2017

Luke Yong-Zheng Chong

2

1 reference

31 October 2017

Poh Yian Cheok

3

1 reference

31 October 2017

Hui Hua Li

4

1 reference

31 October 2017

George Wai-Cheong Yip

5

1 reference

31 October 2017

Boon Huat Bay

6

1 reference

31 October 2017

Gary Man-Kit Tse

7

1 reference

31 October 2017

Jabed Iqbal

8

1 reference

31 October 2017

Puay Hoon Tan

9

1 reference

31 October 2017

publication date

9 August 2013

1 reference

31 October 2017

1 reference

31 October 2017

volume

27

1 reference

31 October 2017

issue

3

1 reference

31 October 2017

page(s)

352-360

1 reference

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Targeted approaches to triple-negative breast cancer: current practice and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

The androgen receptor in breast cancer: learning from the past.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Triple-negative breast cancer: role of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Roles of androgens in the development, growth, and carcinogenesis of the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Immunocytochemical localization of sex steroid hormone receptors in normal human mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Androgens induce divergent proliferative responses in human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Targeting androgen receptor in estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

A new hormonal therapy for estrogen receptor-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Expression of androgen receptors in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Is apocrine differentiation in breast carcinoma of prognostic significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

7 January 2021

Androgens and androgen receptors: a clinically neglected sector in breast cancer biology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

7 January 2021

Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

7 January 2021

Androgen receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

7 January 2021

Apocrine differentiation in human mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

7 January 2021

Breast gross cystic disease protein 15 in human breast cancer in culture

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.145

7 January 2021

10.1038/MODPATHOL.2013.145

Identifiers

DOI

1 reference

Dimensions Publication ID

31 October 2017

1049562019

0 references

Fatcat ID

release_2rlzg3djdvgmfgtpv66plew5uy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2rlzg3djdvgmfgtpv66plew5uy

24 November 2022

mapped directly with Wikidata item

1 reference